Press

"25 Years at the Heart of the Sector": AseBio highlights key milestones in an infographic to mark Its 25th anniversary

13/11/2024

Corporate

• Over the past quarter-century, AseBio has led an “invisible revolution,” playing a crucial role in the profound transformation of Spain's biotech sector.
• AseBio’s 25th-anniversary celebration will take place on November 26 at the Gran Teatro CaixaBank Príncipe Pío in Madrid.
• “AseBio has been and will continue to be a catalyst for innovation, so let’s keep working together to ensure that, over the next 25 years, biotechnology remains a cornerstone of our society and a model of sustainable innovation and progress,” stated its president, Rocío Arroyo.

AseBio

Barcelona establishes itself as the host city for BIOSPAIN for the 2025 and 2027 editions

06/11/2024

BioSpain

•  AseBio, in collaboration with Biocat, the Generalitat of Catalonia, and the Barcelona City Council, will host the next two editions of BIOSPAIN in Barcelona, one of Europe’s most important international biotechnology events. This decision reinforces the Catalan capital’s position as a hub for the sector.
• In its 12th edition, the event is expected to gather over 2,000 professionals from more than 1,000 organizations working in health, agri-food, and sustainable industrial solutions from October 7 to 9, 2025, at Fira de Barcelona.
•  Catalonia's BioRegion leads the national biotechnology ecosystem, excelling in the number of biotech companies, revenue volume, and its ability to attract international investment.
   

AseBio

The Green Innovation Forum 2024 Will analyze the key role of biotechnology in the transition towards a more sustainable economy in Pamplona

04/11/2024

Climate change · Agrifood · Food & feed · Agriculture · Bioeconomy

• The fifth edition, organized by AseBio and the Government of Navarra through the public company Sodena, will take place on November 19 at the Baluarte Congress and Auditorium Palace in Navarra.
• The Green Innovation Forum 2024 is a must-attend event for companies, foundations, and academic institutions in the biotechnology field, as well as for companies and institutions from other industrial sectors with an interest in the green economy sector.
• In addition to a comprehensive program of conferences led by a distinguished group of experts, the event will foster the creation of new business and investment opportunities.
• With over 140 registered attendees, we are on track to reach over 300 participants.

AseBio

Biotechnology plays a crucial role in the latest advances against Alzheimer's

21/09/2024

Healthcare · Innovative drugs · Personalized medicine · Advanced therapies

• Nearly two decades ago, the first group of compounds to treat Alzheimer's disease were approved, but they do not stop the progression of the neurodegenerative process nor restore the neuronal damage it has caused.
• Despite the efforts and enormous resources dedicated to the field of Alzheimer's disease, there is currently no approved treatment that cures this condition.
• Biotechnology is behind every medication being tested and eventually approved, making its contribution the key factor that has enabled improvements in treatments in recent years.
   

AseBio

Biotechnology revolutionizes the diagnosis and treatment of lymphoma, the seventh most common tumor in men and the eighth in women in Spain

15/09/2024

Healthcare · Rare diseases · Innovative drugs · Personalized medicine

• There are more than 40 types of lymphomas that can generally be grouped into two major subgroups: Hodgkin lymphoma and non-Hodgkin lymphoma.
• It is estimated that in 2024, around 12,400 new cases of lymphoma will be diagnosed in Spain, the majority (approximately 85%) being non-Hodgkin.
• Biotechnology has enabled advances such as diagnosis through next-generation sequencing tools, non-invasive detection methods, the development of targeted therapies, immunotherapy with monoclonal antibodies, and nanotechnology.

AseBio

Biotechnology, at the forefront of the fight against sepsis, one of the world's most serious and deadly conditions, with a 20% mortality rate

13/09/2024

Healthcare · Innovative drugs

• Sepsis is a potentially life-threatening condition that occurs when the body's immune system reacts in an extreme way to an infection, causing organ dysfunction. 
• 22% of sepsis survivors who have required intensive care suffer from post-traumatic stress disorder, and 17% of survivors experience moderate to severe cognitive impairment. 
• The use of artificial intelligence or an innovative approach focused on measuring NLRP3 inflammasome activation in monocytes ex vivo are examples of the latest advancements against sepsis.
  
   

AseBio

Biotechnology Applied to Agriculture: Key to Addressing Challenges Such as Hunger, Climate Change, and Population Growth

09/09/2024

Climate change · Agrifood · Food & feed · Agriculture

• The optimization of soil nutrient utilization, crops better adapted to climate change, or maximizing pest control through the digitalization of pesticide application are among the main areas of development.
• Genetic modification offers the opportunity to make more precise, faster, and necessary changes in the face of challenges such as climate change, population growth, and limited resources.
• On November 19, 2024, Pamplona will host the fifth edition of the Green Innovation Forum, which will explore the opportunities biotechnology offers in the transition toward a more sustainable and carbon-neutral economy.

AseBio

AseBio and the Ministry of Health analyze the challenges and opportunities of Artificial Intelligence in health data spaces

25/06/2024

Healthcare · Access to innovation

• The event "Challenges and Opportunities for Spain in the Application of AI in Health Data Spaces," organized by AseBio together with the Ministry of Health, brought together leading organizations from across the value chain to address the specificities and challenges in the use of AI in the healthcare sector.
• We are at a crucial moment for the development of health data spaces at the European, national, and regional levels; these represent an opportunity to lead the improvement of healthcare, data management, and to drive research and new biotechnological developments.
• The event shares experiences from national organizations representing the entire ecosystem, with the aim of eliminating potential knowledge barriers that hinder proper collaboration.
  
   

AseBio

Investment in R&D by biotech companies grows by 17% to 1,218 million euros

12/06/2024

Healthcare · Agrifood · Industrial biotechnology

• In 2022, the activity of biotech companies in Spain generated more than 16.6 billion euros in revenue, representing 1.5% of the national GDP.
• Private funding raised by the sector reached an all-time high, surpassing 228 million euros after a 37% increase.
• The number of biotech companies in Spain grew by 8.5% in 2022, reaching a total of 974.
• Biotech companies maintained the second position in the ranking of sectors with the highest percentage of researchers relative to total employees, with 13.77%.
  
   

AseBio